Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat
Tóm tắt
The spontaneously diabetic Torii (SDT) rat has recently been established as a model of type 2 human diabetes mellitus. Male SDT rats develop severe diabetic ocular complications. This study investigated the nature of the ocular complications in this model and addressed the question of whether the SDT rat is a good model of human proliferative diabetic retinopathy. Male SDT rats aged 50 weeks were studied for a period of 8 months. Under deep anaesthesia, one eye of each animal was enucleated following perfusion with fluorescein dextran and a retinal flat mount was prepared to study vascular structure. The other eye was enucleated and investigated histologically by haematoxylin–eosin and azan staining and by immunohistochemistry using antibodies against vascular endothelium (Griffonia simplicifolia isolectin B4 antibody) and vascular endothelial growth factor (VEGF). From the vascular structure study, 17 of 32 rats (53%) showed proliferative retinopathy without vascular non-perfusion. The histological study revealed traction retinal folds in rats with proliferative retinopathy. Azan staining showed some proliferative matrix in rats with normal retinal structure and those with proliferative retinopathy compared with normoglycaemic controls. Staining with Griffonia simplicifolia isolectin B4 antibody showed no specific vascular changes in any of the rats, while VEGF staining revealed higher immunoreactivity in the retina of rats with normal retinal structure and those with proliferative retinopathy, but only low immunoreactivity in the control animals. There appear to be differences between the SDT rat model of diabetic retinopathy and human proliferative diabetic retinopathy, as the SDT rat develops retinal neovascularisation without retinal ischaemia. This very unique display of ocular neovascularisation may be caused by increased expression of VEGF.
Tài liệu tham khảo
Kern T, Kowlulu R, Engerman R (1994) Questions raised by studies of experimental diabetic retinopathy. Elsevier Science, Japan
Kador PF, Takahashi Y, Wyman M, Ferris F III (1995) Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 113:352–354
Buechi E, Kurosawa A, Tso M (1996) Retinopathy in diabetic hypertensive monkeys: a pathologic study. Graefes Arch Clin Exp Ophthalmol 234:388–398
Sima AA, Chakrabarti S, Garcia-Salinas R, Basu PK (1985) The BB-rat – an authentic model of human diabetic retinopathy. Curr Eye Res 4:1087–1092
Mansford KR, Opie L (1968) Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1:670–671
Hanafusa T, Maiyagawa J, Nakajima H et al (1994) The NOD mouse. Diabetes Res Clin Prac 24[Suppl]:S307–S311
Peterson R, Shaw M, Neel M-A, Eichberg J (1990) Zucker diabetic fatty rat as model for non-insulin-dependent diabetes melllitus. ILAR News 32:16–19
Berdanier CD (1991) The BHE rat: an animal model for the study of non-insulin-dependent diabetes mellitus. FASEB J 5:2139–2144
Kuwano K, Hirashima T, Mori S, Saitoh Y, Kurosumi T, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka–Long–Evans–Tokushima Fatty (OLETF) strain. Diabetes 41:1248–1422
Engerman R, Finkelstein D, Aguirre G et al (1982) Ocular complications. Diabetes 31[Suppl 1]:82–88
Shinohara M, Masuyama T, Shoda T et al (2000) A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 1:89–100
Smith L, Woesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101–111
Masuyama T, Komeda K, Hara A et al (2003) Chronological characterization of diabetes development in male spontaneously diabetic Torii rats. Biochem Biophys Res Commun 314:870–877
Aiello L, Avery R, Arig P et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487
Adamis A, Miller J, Bernal M-T et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450
Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M (1998) Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 152:1453–1462
Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E (1996) Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80:241–245
Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36–47
Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819–825
Sone H, Kawakami Y, Okuda Y et al (1997) Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40:726–730
Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G (1998) Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of rat. Diabetes 47:401–406
Boulton M, Foreman D, Williams G, McLeod D (1998) VEGF localisation in diabetic retinopathy. Br J Ophthalmol 82:561–568
Pierce E, Avery R, Foley E, Aiello L, Smith L (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92:905–909
Rand LI, Prud’homme GJ, Ederer F, Canner PL, Group tDRS (1985) Factors influencing the development of visual loss in advanced diabetic retinopathy. Invest Ophthalmol Vis Sci 26:983–991
Kishi S, Shimizu K (1993) Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology 100:225–229
Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48–58